Keith Matheny, MD
Otolaryngology · Frisco, TXNPI 1205805462
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $166,117 of the $268,926 with a category attached, or 61.8%. 37 manufacturers reported payments, led by Medtronic at 48.3% of the total. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 528 payments — averaging $509.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$130K
- Intersect ENT, Inc.$54K
- Aerin Medical Inc.$27K
- Photonicare Inc$15K
- Olympus Corporation Of The Americas$13K
- Somnomed Inc.$12K
- plus $18K from 31 others
Across 13 payments — averaging $4013.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Intersect ENT, Inc.$35K
- Sanofi US Services Inc.$11K
- Medtronic$5K
- Arrinex, Inc.$721
- Stryker$28
What the payments were for
- Consulting fees$26,61910%
- Speaking & faculty fees$166,11762%
- Travel & lodging$38,46914%
- Food & beverage$20,5398%
- Education$11,7304%
- Other$5,4512%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 188 | $129,766 |
| Intersect ENT, Inc. | 88 | $54,123 |
| Aerin Medical Inc. | 51 | $27,093 |
| Photonicare Inc | 5 | $15,243 |
| Olympus Corporation Of The Americas | 26 | $12,792 |
| Somnomed Inc. | 3 | $12,368 |
| Lazurite Inc. | 1 | $4,451 |
| KARL Storz Endoscopy-america | 1 | $2,180 |
| Stryker | 34 | $2,140 |
| AstraZeneca | 6 | $1,862 |
| Itamar Medical Inc | 4 | $1,117 |
| Olympus America Inc. | 7 | $856 |
| Inspire Medical Systems, Inc. | 11 | $801 |
| Smith+Nephew | 11 | $738 |
| Acclarent, Inc | 13 | $487 |
| Regeneron Healthcare Solutions, Inc. | 17 | $396 |
| Amgen | 7 | $373 |
| Sanofi | 9 | $329 |
| Alk-abello, Inc | 10 | $296 |
| Xoran Technologies LLC | 3 | $283 |
| Preceptis Medical, Inc. | 1 | $253 |
| Optinose US, Inc. | 12 | $228 |
| Spirair, Inc. | 1 | $151 |
| 3b Medical, Inc. | 1 | $111 |
| Chitogel Limited | 1 | $87 |
| Ensodata, Inc. | 1 | $65 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $54 |
| Arrinex, Inc. | 1 | $46 |
| GSK | 3 | $45 |
| Phadia US Inc. | 3 | $43 |
| Neurent Medical Limited | 1 | $34 |
| Kaleo, Inc. | 1 | $27 |
| Merck | 1 | $24 |
| Advanced Bionics, LLC | 1 | $20 |
| Novartis | 1 | $19 |
| Cook Medical LLC | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$91,753
- SINUVA$29,476
- VIVAER STYLUS$25,846
- OtoSight Middle Ear Scope$15,243
- Celon System$12,893
- PK Diego$12,462
- Olympus ENT Instruments$12,462
- Olympus Rhinology Instruments$11,730
- NUVENT$8,501
- AUTOCON$2,180
- TEZSPIRE$1,756
- RHINAER STYLUS$1,540
- WatchPATONE$1,101
- Inspire$548
- Hummingbird Tympanostomy Tube System$505
- TULA$504
- VenSure$438
- Coblation$400
- SCOPIS ENT$327
- XPRESS ENT DILATION SYSTEM$315
How this compares
$268,926 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 38 | $1,007 |
| Azithromycin | 13 | $270 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Frisco
- Dale EhmerFrisco$24K
- Marc DeanFort Worth$486K
- Amber LuongHouston$426K
- Arjuna KuperanHouston$348K
- Ronald KuppersmithCollege Station$325K
- Ron KarniHouston$317K
- Philip ChenSan Antonio$305K
- Jordan RihaniSouthlake$280K
- Martin CitardiHouston$245K
- James AtkinsSan Antonio$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.